ARTICLE | Company News
Biodel, Albireo deal
November 17, 2016 10:50 PM UTC
Albireo and Biodel merged to form Albireo Pharma Inc. (NASDAQ:ALBO, Boston, Mass.). The company plans to start a pivotal trial of lead compound A4250 next year to treat progressive familial intrahepa...